Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine
Placental malaria is a public health burden particularly in Africa as it causes severe symptoms and results in stillbirths or maternal deaths. Plasmodium falciparum protein VAR2CSA drives placental malaria (PM) in pregnant women by adhering to chondroitin sulfate A (CSA) on the placenta. VAR2CSA is...
Main Authors: | Jasmita Gill, Soumyananda Chakraborti, Praveen Bharti, Amit Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971221006871 |
Similar Items
-
VAR2CSA-Mediated Host Defense Evasion of Plasmodium falciparum Infected Erythrocytes in Placental Malaria
by: Alice Tomlinson, et al.
Published: (2021-02-01) -
Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens
by: Chathura Siriwardhana, et al.
Published: (2017-09-01) -
Can complement fix placental malaria?
by: Justin Y. A. Doritchamou, et al.
Published: (2021-09-01) -
Progress and Insights Toward an Effective Placental Malaria Vaccine
by: Benoît Gamain, et al.
Published: (2021-02-01) -
Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes
by: Michal Fried, et al.
Published: (2018-03-01)